Metraipolis › archive › dc_2d6142adb280
Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41647517
- DOI
- 10.3389/fmed.2026.1738610
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T15:28:35.067Z
- SHA-256 of the archived text
ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6- Stable URL of this page
https://metraipolis.com/documento/dc_2d6142adb280
How to cite
Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517 — Europe PMC (en), https://europepmc.org/article/MED/41647517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d6142adb280 (Metraipolis archive dc_2d6142adb280, sha256 ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6)
BibTeX
@misc{dc2d6142adb280,
title = {Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study — Europe PMC PMID:41647517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41647517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d6142adb280; sha256 ea295875fa84bdc61707df2d4125aa76b42cfd7d751d4cf79e5d093650a186b6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41647517. Agents can read the archived copy with the MCP tool read_document.